INR 873.9
(1.21%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 10.66 Million INR | -46.59% |
2022 | 19.97 Million INR | -2.27% |
2021 | 20.43 Million INR | 293.23% |
2020 | 5.19 Million INR | -98.45% |
2019 | 336.08 Million INR | -0.0% |
2018 | 336.08 Million INR | -45.16% |
2017 | 612.86 Million INR | -3.84% |
2016 | 637.31 Million INR | -16.42% |
2015 | 762.48 Million INR | 0.12% |
2014 | 761.53 Million INR | 12.49% |
2013 | 677 Million INR | -6.58% |
2012 | 724.68 Million INR | 13.49% |
2011 | 638.52 Million INR | 51.68% |
2010 | 420.96 Million INR | 41.36% |
2009 | 297.8 Million INR | 91.14% |
2008 | 155.8 Million INR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q3 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 10.66 Million INR | -46.59% |
2023 Q4 | 10.66 Million INR | 0.0% |
2023 Q2 | 8.97 Million INR | 0.0% |
2022 Q4 | 19.97 Million INR | 0.0% |
2022 FY | 19.97 Million INR | -2.27% |
2022 Q2 | 119.57 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2021 Q4 | 20.43 Million INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 20.43 Million INR | 293.23% |
2021 Q2 | 110 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 FY | 5.19 Million INR | -98.45% |
2020 Q3 | - INR | -100.0% |
2020 Q4 | 5.19 Million INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2020 Q2 | 181.79 Million INR | 0.0% |
2019 Q3 | - INR | -100.0% |
2019 Q1 | - INR | -100.0% |
2019 Q2 | 366.91 Million INR | 0.0% |
2019 Q4 | 336.08 Million INR | 0.0% |
2019 FY | 336.08 Million INR | -0.0% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 365.16 Million INR | 0.0% |
2018 Q1 | - INR | -100.0% |
2018 FY | 336.08 Million INR | -45.16% |
2018 Q4 | 336.08 Million INR | 0.0% |
2017 FY | 612.86 Million INR | -3.84% |
2017 Q3 | - INR | -100.0% |
2017 Q1 | - INR | -100.0% |
2017 Q4 | 612.86 Million INR | 0.0% |
2017 Q2 | 502.94 Million INR | 0.0% |
2016 Q3 | - INR | -100.0% |
2016 FY | 637.31 Million INR | -16.42% |
2016 Q4 | 637.31 Million INR | 0.0% |
2016 Q2 | 616.75 Million INR | 0.0% |
2016 Q1 | - INR | -100.0% |
2015 FY | 762.48 Million INR | 0.12% |
2015 Q3 | - INR | -100.0% |
2015 Q2 | 638.16 Million INR | 0.0% |
2015 Q4 | 762.48 Million INR | 0.0% |
2015 Q1 | - INR | -100.0% |
2014 Q1 | - INR | -100.0% |
2014 Q4 | 761.53 Million INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2014 FY | 761.53 Million INR | 12.49% |
2014 Q2 | 933.82 Million INR | 0.0% |
2013 FY | 677 Million INR | -6.58% |
2013 Q3 | - INR | -100.0% |
2013 Q4 | 677 Million INR | 0.0% |
2013 Q1 | - INR | -100.0% |
2013 Q2 | 826.41 Million INR | 0.0% |
2012 Q4 | 724.68 Million INR | 0.0% |
2012 Q2 | - INR | 0.0% |
2012 Q3 | - INR | 0.0% |
2012 FY | 724.68 Million INR | 13.49% |
2011 Q4 | 638.52 Million INR | 0.0% |
2011 FY | 638.52 Million INR | 51.68% |
2010 FY | 420.96 Million INR | 41.36% |
2009 FY | 297.8 Million INR | 91.14% |
2008 FY | 155.8 Million INR | 0.0% |
2008 Q4 | 155.8 Million INR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Sigachi Industries Limited | 1.43 Billion INR | 99.254% |
Ind-Swift Limited | 10.13 Billion INR | 99.895% |
Bajaj HealthCare Limited | 3.32 Billion INR | 99.679% |
Sakar Healthcare Limited | 793.51 Million INR | 98.656% |
Aurobindo Pharma Limited | 66.47 Billion INR | 99.984% |
Innova Captab Limited | 2.45 Billion INR | 99.565% |
Divi's Laboratories Limited | 30 Million INR | 64.44% |
AstraZeneca Pharma India Limited | 45.98 Million INR | 76.8% |
Morepen Laboratories Limited | 289.99 Million INR | 96.321% |
Mankind Pharma Limited | 2.07 Billion INR | 99.485% |
Sequent Scientific Limited | 4.87 Billion INR | 99.781% |
Wanbury Limited | 1.16 Billion INR | 99.084% |
Laurus Labs Limited | 25.77 Billion INR | 99.959% |
Nectar Lifesciences Limited | 6.35 Billion INR | 99.832% |
Glenmark Life Sciences Limited | 171.48 Million INR | 93.779% |
Alembic Limited | 91.5 Million INR | 88.341% |
Hikal Limited | 8.17 Billion INR | 99.87% |
Alembic Pharmaceuticals Limited | 5.13 Billion INR | 99.792% |
Neuland Laboratories Limited | 953.89 Million INR | 98.882% |
J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 99.718% |
Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 99.913% |
IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | 96.744% |
Themis Medicare Limited | 957.92 Million INR | 98.886% |
RPG Life Sciences Limited | - INR | -Infinity% |
Zydus Lifesciences Limited | 8.04 Billion INR | 99.867% |
Lupin Limited | 29.21 Billion INR | 99.963% |
Amrutanjan Health Care Limited | 17.28 Million INR | 38.275% |
Wockhardt Limited | 23.56 Billion INR | 99.955% |
Vaishali Pharma Limited | 134.91 Million INR | 92.093% |
Aarti Pharmalabs Limited | 2.85 Billion INR | 99.626% |
Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | 88.068% |
Jubilant Pharmova Limited | 36.64 Billion INR | 99.971% |
FDC Limited | 205.18 Million INR | 94.801% |
Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 99.947% |
Kilitch Drugs (India) Limited | 316.46 Million INR | 96.629% |
Eris Lifesciences Limited | 27.81 Billion INR | 99.962% |
Venus Remedies Limited | 413.3 Million INR | 97.419% |
ZIM Laboratories Limited | 1.08 Billion INR | 99.02% |
Bliss GVS Pharma Limited | 998.4 Million INR | 98.931% |
Par Drugs and Chemicals Limited | - INR | -Infinity% |
Caplin Point Laboratories Limited | 19.7 Million INR | 45.848% |
Shilpa Medicare Limited | 9.37 Billion INR | 99.886% |
Albert David Limited | 33.24 Million INR | 67.908% |
Ajanta Pharma Limited | 352.8 Million INR | 96.976% |
Hester Biosciences Limited | 2.44 Billion INR | 99.563% |
Suven Pharmaceuticals Limited | 649.96 Million INR | 98.359% |
Solara Active Pharma Sciences Limited | 10.11 Billion INR | 99.895% |
Gufic Biosciences Limited | 3.32 Billion INR | 99.68% |
Windlas Biotech Limited | 36.41 Million INR | 70.7% |
Procter & Gamble Health Limited | 95.6 Million INR | 88.841% |
Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | 96.597% |
Mangalam Drugs & Organics Limited | 984.92 Million INR | 98.917% |
Granules India Limited | 13.15 Billion INR | 99.919% |
Aarti Drugs Limited | 5.64 Billion INR | 99.811% |
Bal Pharma Limited | 1.39 Billion INR | 99.236% |
Alkem Laboratories Limited | 14.18 Billion INR | 99.925% |
Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 99.967% |
Medicamen Biotech Limited | 308.17 Million INR | 96.538% |
Unichem Laboratories Limited | 2.47 Billion INR | 99.569% |
Bafna Pharmaceuticals Limited | 243.89 Million INR | 95.626% |
Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -143.062% |
Valiant Laboratories Limited | 767.08 Million INR | 98.609% |
Orchid Pharma Limited | 1.35 Billion INR | 99.211% |
Medico Remedies Limited | 80.5 Million INR | 86.748% |
Ind-Swift Laboratories Limited | 166.21 Million INR | 93.582% |
Ipca Laboratories Limited | 14.38 Billion INR | 99.926% |
Brooks Laboratories Limited | 56.41 Million INR | 81.091% |
Syncom Formulations (India) Limited | 724.86 Million INR | 98.528% |
Piramal Enterprises Limited | 535.85 Billion INR | 99.998% |
Torrent Pharmaceuticals Limited | 40.22 Billion INR | 99.973% |
NATCO Pharma Limited | 3.71 Billion INR | 99.713% |
Suven Life Sciences Limited | 7.09 Million INR | -50.317% |
Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 99.448% |
Strides Pharma Science Limited | 25.16 Billion INR | 99.958% |
Indoco Remedies Limited | 6.71 Billion INR | 99.841% |
Alpa Laboratories Limited | 52.46 Million INR | 79.666% |
Lasa Supergenerics Limited | 220.76 Million INR | 95.168% |
Sun Pharma Advanced Research Company Limited | 611.5 Million INR | 98.255% |